To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
Da Shi, Damian Beasock, Adam B. Fessler, János Szebeni, Julia Y. Ljubimova, Kirill A. Afonin, Marina A. Dobrovolskaia
Topics & Concepts
Polyethylene glycolNanomedicinePEG ratioBiodistributionPEGylationContext (archaeology)ImmunogenicityPharmacologyNanotechnologyDrugDrug carrierChemistryMedicineMaterials scienceNanoparticleImmunologyImmune systemBiologyBiochemistryIn vitroBusinessPaleontologyFinanceRNA Interference and Gene DeliveryImmunotherapy and Immune ResponsesNanoparticle-Based Drug Delivery